Public Sector Pension Investment Board Sells 11,216 Shares of HCA Healthcare, Inc. $HCA

14 Dec 2025, 10:44 by Tristan Rich · The Markets Daily

Public Sector Pension Investment Board trimmed its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 6.5% in the 2nd quarter, Holdings Channel.com reports. The firm owned 162,634 shares of the company’s stock after selling 11,216 shares during the period. Public Sector Pension Investment Board’s holdings in HCA Healthcare were worth $62,305,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in HCA. Norges Bank purchased a new stake in shares of HCA Healthcare in the second quarter worth $1,152,408,000. Price T Rowe Associates Inc. MD grew its position in HCA Healthcare by 83.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock valued at $829,104,000 after purchasing an additional 1,091,416 shares during the last quarter. Viking Global Investors LP lifted its stake in shares of HCA Healthcare by 58.5% in the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after buying an additional 690,773 shares in the last quarter. Nordea Investment Management AB increased its position in shares of HCA Healthcare by 6.8% during the second quarter. Nordea Investment Management AB now owns 927,781 shares of the company’s stock valued at $350,404,000 after acquiring an additional 59,163 shares in the last quarter. Finally, LSV Asset Management lifted its position in HCA Healthcare by 0.4% in the 2nd quarter. LSV Asset Management now owns 868,849 shares of the company’s stock valued at $332,856,000 after acquiring an additional 3,396 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on HCA shares. TD Cowen upped their price target on HCA Healthcare from $380.00 to $490.00 and gave the company a “buy” rating in a report on Monday, October 27th. Jefferies Financial Group raised their price target on shares of HCA Healthcare from $485.00 to $525.00 and gave the company a “buy” rating in a report on Tuesday, October 28th. Mizuho increased their price objective on shares of HCA Healthcare from $475.00 to $505.00 and gave the company an “outperform” rating in a research report on Monday, October 27th. Royal Bank Of Canada boosted their target price on shares of HCA Healthcare from $449.00 to $482.00 and gave the company an “outperform” rating in a research note on Monday, October 27th. Finally, Wall Street Zen raised HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Saturday, October 25th. Fourteen analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. According to MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $475.95.

Check Out Our Latest Stock Report on HCA Healthcare

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the sale, the executive vice president owned 3,487 shares in the company, valued at approximately $1,652,105.73. This represents a 52.74% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $484.67 on Friday. The stock’s fifty day moving average is $465.59 and its 200 day moving average is $413.86. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $520.00. The stock has a market cap of $110.60 billion, a P/E ratio of 18.73, a P/E/G ratio of 1.43 and a beta of 1.36.

HCA Healthcare (NYSE:HCA – Get Free Report) last posted its quarterly earnings data on Friday, October 24th. The company reported $6.96 EPS for the quarter, topping the consensus estimate of $5.64 by $1.32. The firm had revenue of $19.16 billion for the quarter, compared to the consensus estimate of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The business’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same quarter last year, the company earned $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be given a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.13%.

About HCA Healthcare

(Free Report)